— Know what they know.
Not Investment Advice

KOD NASDAQ

Kodiak Sciences Inc.
1W: -3.3% 1M: -17.2% 3M: +48.0% YTD: +43.8% 1Y: +821.4% 3Y: +542.8% 5Y: +122.5%
$36.23
-1.18 (-3.15%)
 
Weekly Expected Move ±7.2%
$32 $34 $37 $40 $42
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $1.9B mcap · 49M float · 2.19% daily turnover · Short 76% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$27M -2.9% ▼
Operating Income
-$187M +32.6% ▲
Net Income
-$176M +32.4% ▲
EPS (Diluted)
$-3.35 +32.6% ▲
EBITDA
-$150M +36.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$4M$9M$11M$26M$27M
Gross Profit-$4M-$9M-$11M-$26M-$27M
Gross Margin
R&D Expenses$107M$217M$268M$206M$126M
SG&A Expenses$24M$41M$63M$71M$34M
Operating Expenses$132M$258M$330M$251M$160M
Operating Income-$136M-$267M-$341M-$277M-$187M
Operating Margin
Interest Expense$25K$22K$18K$13K$0
Income Before Tax-$133M-$267M-$334M-$260M-$176M
Tax Expense$0$0$0$0$0
Net Income-$133M-$267M-$334M-$260M-$176M
Net Margin
EPS (Diluted)$-2.91$-5.16$-6.39$-4.97$-3.35
EBITDA-$129M-$258M-$323M-$235M-$150M
Shares Outstanding46M52M52M52M53M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms